Overt Proteinuria, Moderately Reduced eGFR and Their Combination Are Predictive of Severe Diabetic Retinopathy or Diabetic Macular Edema in Diabetes

被引:20
|
作者
Yamamoto, Masahiko [1 ]
Fujihara, Kazuya [1 ]
Ishizawa, Masahiro [1 ]
Osawa, Taeko [1 ]
Kaneko, Masanori [1 ]
Ishiguro, Hajime [1 ]
Matsubayashi, Yasuhiro [1 ]
Seida, Hiroyasu [2 ]
Yamanaka, Nauta [2 ]
Tanaka, Shiro [3 ]
Kodama, Satoru [1 ]
Hasebe, Hiruma [4 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, 1-757 Asahimachi, Niigata, Niigata 9518510, Japan
[2] Japan Med Data Ctr Co Ltd, Tokyo, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Clin Biostat, Kyoto, Japan
[4] Niigata Univ, Fac Med, Dept Ophthalmol, Niigata, Japan
基金
日本学术振兴会;
关键词
overt proteinuria; moderately reduced eGFR; vision-threatening treatment-required diabetic eye diseases; INTRAVITREAL BEVACIZUMAB; MICROALBUMINURIA; DISEASE; IMPACT;
D O I
10.1167/iovs.19-26749
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Since the combined effects of proteinuria and a moderately decreased eGFR on incident severe eye complications in patients with diabetes are still largely unknown, these associations were determined in a large historical cohort of Japanese patients with diabetes mellitus. METHODS. We evaluated the effects of overt proteinuria (OP) (dipstick 1+ and over) and/or moderately reduced estimated glomerular filtration rate (eGFR) (MG) (baseline eGFR 30.0-54.9 mL/min/1.73 m(2)) on the incidence of treatment-required diabetic eye diseases (TRDED). We divided 7709 patients into four groups according to the presence or absence of OP and MG: no OP without MG (NP[MG-]), OP without MG (OP[MG-]), no OP with MG (NP[MG+]), and OP with MG (OP[MG+]). Multivariate Cox analyses were performed to calculate hazard ratios (HRs) with 95% confidence intervals for combinations of the presence and/or absence of OP and MG on the risk of developing TRDED. RESULTS. During the median follow-up period of 5.6 years, 168 patients developed TRDED. HRs for OP and MG for incident TRDED were 1.91 (95% confidence interval, 1.27-2.87) and 1.90 (1.11-3.23), respectively. HRs for incident TRDED were 1.73 (1.11-2.69) and 5.57 (2.40-12.94) for OP(MG-) and OP(MG+), respectively, in comparison with NP(MG-). CONCLUSIONS. In Japanese patients with diabetes, OP and MG were separately as well as additionally associated with higher risks of TRDED. Results indicate the necessity of the simultaneous assessment of proteinuria and eGFR for appropriate evaluation of risks of severe eye complications in patients with diabetes.
引用
收藏
页码:2685 / 2689
页数:5
相关论文
共 50 条
  • [41] Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
    Lee, Ryan
    Wong, Tien Y.
    Sabanayagam, Charumathi
    [J]. EYE AND VISION, 2015, 2
  • [42] Severe macular edema induced by pioglitazone in a patient with diabetic retinopathy: a case study
    Oshitari, Toshiyuki
    Asaumi, Noriko
    Watanabe, Masaru
    Kumagai, Ken
    Mitamura, Yoshinori
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (05) : 1137 - 1140
  • [43] Definition, classification and visual aspects of diabetes mellitus, diabetic retinopathy and diabetic macular edema: A review of literature
    Sukha, A. Y.
    Rubin, A.
    [J]. AFRICAN VISION AND EYE HEALTH JOURNAL, 2007, 66 (03): : 120 - 131
  • [44] Pegaptanib Sodium for the Treatment of Proliferative Diabetic Retinopathy and Diabetic Macular Edema
    Giuliari, Gian P.
    Guel, David A.
    Gonzalez, Victor H.
    [J]. CURRENT DIABETES REVIEWS, 2009, 5 (01) : 33 - 38
  • [45] Role of Steroids in the Management of Diabetic Macular Edema and Proliferative Diabetic Retinopathy
    Silva, Paolo S.
    Sun, Jennifer K.
    Aiello, Lloyd Paul
    [J]. SEMINARS IN OPHTHALMOLOGY, 2009, 24 (02) : 93 - 99
  • [46] Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy
    John R. O’Fee
    Joseph Juliano
    Andrew A. Moshfeghi
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2191 - 2200
  • [47] Association of periodontitis and diabetic macular edema in various stages of diabetic retinopathy
    Lindner, Marlene
    Arefnia, Behrouz
    Ivastinovic, Domagoj
    Sourij, Harald
    Lindner, Ewald
    Wimmer, Gernot
    [J]. CLINICAL ORAL INVESTIGATIONS, 2022, 26 (01) : 505 - 512
  • [48] Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy
    O'Fee, John R.
    Juliano, Joseph
    Moshfeghi, Andrew A.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (07) : 2191 - 2200
  • [49] Foveal choroidal thickness in patients with diabetic retinopathy and diabetic macular edema
    Varughese, Rachel Sarah
    Rewbury, Rebecca
    Want, Andrew
    Chong, Victor
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [50] Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy
    Yoo-Ri Chung
    Sung Wook Park
    Shin-Young Choi
    Seung Woo Kim
    Ka Young Moon
    Jeong Hun Kim
    Kihwang Lee
    [J]. Cardiovascular Diabetology, 16